Clinical significance of ApoE expression in human gastric cancer

Oncology Reports

Volumn 20, Issue 6, 2008, Pages 1313-1319

  Sakashia, Katsuya ^a,b   Tanaka, Fumiaki ^a   Zhang, Xiang ^a,b   Mimori, Koshi ^a   Kamohara, Yukio ^a   Inoue, Hiroshi ^a   Sawada, Tetsuji ^b   Hirakawa, Kosei ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein E; Gastric cancer; Muscular invasion

Indexed keywords

APOLIPOPROTEIN E; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MUSCLE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL TIME; AGED; BIOSYNTHESIS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; MIDDLE AGED; MORTALITY; STOMACH; STOMACH TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

AGED; APOLIPOPROTEINS E; CELL LINE, TUMOR; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 59249103247     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000146     Document Type: Article

References (31)

1. Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology and treatment. Ann Oncol 14: 31-36, 2003.
2. Tanaka M, Ono H, Hasuike N and Takizawa K: Endoscopic submucosal dissection of early gastric cancer. Digestion 77: 23-28, 2008.
3. Yasui W, Oue N, Ito R, Kuraoka K and Nakayama H: Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95: 385-392, 2004.
4. Wang L, Zhu JS, Song MQ, Chen GQ and Chen JL: Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser micro-dissection and cDNA microarray. World J Gastroenterol 12: 6949-6954, 2006.
5. Terashima M, Maesawa C, Oyama K, et al: Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92: 1130-1136, 2005.
6. Oue N, Hamai Y, Mitani, et al: Gene expression profile of gastric carcinoma: Identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405, 2004.
7. Mahley RW: Apolipoprotein E: cholesterol transport protein with an expanding role on cell biology. Science 240: 622-630, 1988.
8. Li Y, Cam J and Bu G: Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol Neurobiol 23: 53-67, 2001.
9. Ho YY, Deckelbaum RJ, Chen Y, Vogel T and Talmage DA: Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation. J Biol Chem 276: 43455-43462, 2001.
10. Mahley RW and Rall SC Jr: Apolipoprotein E: far more a lipid transport protein. Annu Rev Genomics Hum Genet 1: 507-537, 2000.
11. Rubinsztein DC, Hanlon CS, Irving RM, et al: Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 8: 519-525, 1994.
12. Ishigami M, Swertfeger DK, Hui MS, Granholm NA and Hui DY: Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 20: 1020-1026, 2000.
13. Williams H, Johnson JL, Carson KG and Jackson CL: Characteristics of intact and ruputured atherosclerotic plaques in brachiocephalic arteries of Apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 22: 788-792, 2002.
14. Chen YC, Pohl G, Wang TL, et al: Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res 65: 331-337, 2005.
15. Dupont-Wallois L, Soulié C, Sergeant N, et al: ApoE synthesis in human neuroblastoma cells. Neurobiol Dis 4: 356-364, 1997.
16. Venanzoni MC, Giunta S, Muraro GB, et al: Apolipoprotein E expression in localized prostate cancers. Int J Oncol 22: 779-786, 2003.
17. Ohmachi T, Tanaka F, Mimori K, Inoue H and Yanaga K: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006.
18. Japanese Gastric Cancer Association: Japanese Classification of Gastric Cancer, 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
19. Jass JR, Sobin LH and Watanabe H: The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 66: 2162-2167, 1990.
20. Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M and Mori M: Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. Int J Oncol 31: 333-338, 2007.
21. Mazzone T: Apolipoprotein E secretion by macrophages: its potential physiological functions. Curr Opin Lipidol 7: 303-307, 1996.
22. Zannis VI, Cole FS, Jackson CL, Kurnit DM and Karathanasis SK: Distribution of Apolipoprotein AI, CI, CIII and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry 24: 4450-4455, 1985.
23. Niemi M, Häkkinen T, Karttunen TJ, et al: Apolipoprotein E and colon cancer expression in normal and malignant human intestine and effect on cultured human colonic adenocarcinoma cells. Eur J Intern Med 13: 37-43, 2002.
24. Akashi K, Yanai H, Nishikawa J, Satake M, Fukagawa Y, Okamoto T and Sakaida I: Ulcerous change decreases the accuracy of endoscopic ultrasonography diagnosis for the invasive depth of early gastric cancer. Int J Gastrointest Cancer 37: 133-138, 2006.
25. Kim JH, Song KS, Youn YH, Lee YC, Cheon JH, Song SY and Chung JB: Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc 66: 901-908, 2007.
26. Raffai RL, Dong LM, Farese RV Jr and Weisgraber KH: Introduction of human apolipoprotein E4 'domain interaction' into mouse apolipoprotein E. Proc Natl Acad Sci USA 98: 11587-11591, 2001.
27. Zunarelli E, Nicoll J, Migaldi M and Trentini GP: Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome. Breast Cancer Res Treat 63: 193-198, 2000.
28. Kervinen K, Södervik H, Mäkelä J, Lehtola J, Niemi M, Kairaluoma MI and Kesäniemi YA: Is the development of adenoma and carcinoma in proximal colon related to Apolipoprotein E phenotype? Gastroenterology 110: 1785-1790, 1996.
29. Niemi M, Kervinen K, Kiviniemi H, et al: Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health 54: 938-939, 2000.
30. Slattery ML, Sweeney C, Murtaugh M, et al: Associations between apoE genotype and colon and rectal cancer. Carcinogenesis 26: 1422-1429, 2005.
31. Zunarelli E, Nicoll JAR and Trentini GP: Apolipoprotein E polymorphism and central nervous system tumors: correlation with cell proliferation indices and clinical outcome. Clin Neuropathol 19: 1-7, 2000.